Atlas FDA

Axonics Sacral Neuromodulation System

FDA premarket approval P180046/S054 · decided 2023-02-07

Approval details

PMA number
P180046
Supplement
S054
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Axonics Sacral Neuromodulation System
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Boston Scientific Corporation
Date received
2022-04-15
Decision date
2023-02-07
Days to decision
298 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Marlborough, MA
Statement
Approval for a labeling expansion to '1.5T MRI conditional' for the Axonics Sacral Neuromodulation System in two clinical scenarios: 1) abandoned lead fragment (i.e., no implanted pulse generator in the body); and 2) a broken lead connected with an intact, rechargeable, implanted pulse generator.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27